Lipoprotein(a) levels and carotid intima-media thickness in children: A 20-year follow-up study

J Clin Lipidol. 2024 Mar-Apr;18(2):e290-e294. doi: 10.1016/j.jacl.2023.11.014. Epub 2023 Nov 27.

Abstract

Elevated lipoprotein(a) [Lp(a)] is independently associated with cardiovascular disease (CVD). In a recent long-term follow-up study involving children with familial hypercholesterolemia (FH), Lp(a) levels contributed significantly to early atherosclerosis, as measured by carotid intima-media thickness (cIMT). To determine if this holds true for children without FH, we conducted a 20-year follow-up study, examining 88 unaffected siblings (mean age: 12.9 years) of children with FH. No significant association was found between Lp(a) and cIMT during follow-up (ß-adjusted [95% confidence interval] = 0.0001 [-0.008 to 0.008] mm per 50 nmol/L increase Lp(a), p = 0.97). In conclusion, our findings suggest that elevated levels of Lp(a) do not play a significant role in arterial wall thickening among children without FH during the 20-year follow-up period. This leads us to consider the possibility that cIMT may not be a suitable marker for detecting potential subtle changes in the arterial wall mediated by Lp(a) in the young, general population. However, it could also be that elevated Lp(a) is only a significant risk factor for atherosclerosis in the presence of other risk factors such as FH.

Keywords: Carotid intima-media thickness; Children; Lipoprotein(a); Lp(a); cIMT.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Carotid Intima-Media Thickness*
  • Child
  • Female
  • Follow-Up Studies
  • Humans
  • Hyperlipoproteinemia Type II* / blood
  • Lipoprotein(a)* / blood
  • Male
  • Risk Factors

Substances

  • Lipoprotein(a)